Notice of Closed Meeting, 97007 [2024-28511]
Download as PDF
<![CDATA[
97007
Federal Register / Vol. 89, No. 235 / Friday, December 6, 2024 / Notices
CDC requests OMB approval for three
years and an estimated 46 annual
burden hours. There are no changes to
the content of the information collection
instrument or the estimated burden per
response.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
PHHS Block Grant Coordinator or
Designee.
PHHS Block Grant Assessment ......
61
1
45/60
46
Total ...........................................
...........................................................
........................
........................
........................
46
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–28688 Filed 12–5–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, pursuant to Public Law 92–
463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE25–032, Formative Research and
Pilot-Testing of Community-led Primary
Prevention Approaches to Address
Elevated Risk of Intimate Partner
Violence & Sexual Violence.
Dates: April 1–2, 2025.
Times: 10 a.m.–5 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Carlisha Gentles, Pharm.D., B.C.P.S.,
C.D.C.E.S., Scientific Review Officer,
National Center for Injury Prevention
and Control, Centers for Disease Control
VerDate Sep<11>2014
18:02 Dec 05, 2024
Jkt 265001
and Prevention, 4770 Buford Highway
NE, Mailstop S106–9, Atlanta, Georgia
30341. Telephone: (770) 488–1504;
Email: CGentles@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–28512 Filed 12–5–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, pursuant to Public Law 92–
463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Control Special Emphasis Panel (SEP)—
CE25–029, Grants to Support New
Investigators in Conducting Research
Related to Preventing Interpersonal
Violence Impacting Children and Youth.
Dates: March 11–12, 2025.
Times: 10 a.m.–5 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341.
Telephone: (404) 639–6473; Email:
AWilkes@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–28511 Filed 12–5–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–25–23FN]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Menthol-
E:\FR\FM\06DEN1.SGM
06DEN1
]]>Agencies
[Federal Register Volume 89, Number 235 (Friday, December 6, 2024)]
[Notices]
[Page 97007]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28511]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention, pursuant to Public Law 92-
463. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--CE25-029, Grants to Support New
Investigators in Conducting Research Related to Preventing
Interpersonal Violence Impacting Children and Youth.
Dates: March 11-12, 2025.
Times: 10 a.m.-5 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Aisha L. Wilkes, M.P.H.,
Scientific Review Officer, National Center for Injury Prevention and
Control, Centers for Disease Control and Prevention, 4770 Buford
Highway NE, Mailstop S106-9, Atlanta, Georgia 30341. Telephone: (404)
639-6473; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-28511 Filed 12-5-24; 8:45 am]
BILLING CODE 4163-18-P
